53 related articles for article (PubMed ID: 34370483)
1. ERK-Peptide-Inhibitor-Modified Ferritin Enhanced the Therapeutic Effects of Paclitaxel in Cancer Cells and Spheroids.
Dong Y; Ma Y; Li X; Wang F; Zhang Y
Mol Pharm; 2021 Sep; 18(9):3365-3377. PubMed ID: 34370483
[TBL] [Abstract][Full Text] [Related]
2. tLyP-1 Peptide Functionalized Human H Chain Ferritin for Targeted Delivery of Paclitaxel.
Ma Y; Li R; Dong Y; You C; Huang S; Li X; Wang F; Zhang Y
Int J Nanomedicine; 2021; 16():789-802. PubMed ID: 33568906
[TBL] [Abstract][Full Text] [Related]
3. Polymeric nanofiber leveraged co-delivery of anti-stromal PAK1 inhibitor and paclitaxel enhances therapeutic effects in stroma-rich 3D spheroid models.
M R H Mostafa A; Petrai O; Poot AA; Prakash J
Int J Pharm; 2024 May; 656():124078. PubMed ID: 38569978
[TBL] [Abstract][Full Text] [Related]
4. Hydrophobicity-enhanced ferritin nanoparticles for efficient encapsulation and targeted delivery of hydrophobic drugs to tumor cells.
Incocciati A; Kubeš J; Piacentini R; Cappelletti C; Botta S; Bertuccini L; Šimůnek T; Boffi A; Macone A; Bonamore A
Protein Sci; 2023 Dec; 32(12):e4819. PubMed ID: 37883077
[TBL] [Abstract][Full Text] [Related]
5. Release of a novel peptide from ferritin nanocages: A new tool for therapeutic applications.
Canè C; Lucignano R; Di Somma A; Liccardo M; Iannuzzi C; Duilio A; Picone D
Biochim Biophys Acta Gen Subj; 2024 Feb; 1868(2):130525. PubMed ID: 38043914
[TBL] [Abstract][Full Text] [Related]
6. Engineered protein cages with enhanced extracellular drug release for elevated antitumor efficacy.
Yan W; Li H; Ning J; Huang S; Jiang L; Xu P; Huang M; Yuan C
Int J Biol Macromol; 2024 May; 267(Pt 1):131492. PubMed ID: 38604418
[TBL] [Abstract][Full Text] [Related]
7. Enzyme-Induced Shape-Shifting Peptide Nanocarrier Coloaded with Paclitaxel and Dipyridamole Inhibits Platelet Function and Tumor Metastasis.
Meng F; Zhai X; Ma J; Li A; Wang X; Bai J
ACS Appl Mater Interfaces; 2024 Jan; 16(1):166-177. PubMed ID: 38143309
[TBL] [Abstract][Full Text] [Related]
8. Encapsulation of Gold-Based Anticancer Agents in Protease-Degradable Peptide Nanofilaments Enhances Their Potency.
Marciano Y; Del Solar V; Nayeem N; Dave D; Son J; Contel M; Ulijn RV
J Am Chem Soc; 2023 Jan; 145(1):234-246. PubMed ID: 36542079
[TBL] [Abstract][Full Text] [Related]
9. Glycolysis-based drug delivery nanosystems for therapeutic use in tumors and applications.
Geng C; Pang S; Ye R; Shi J; Yang Q; Chen C; Wang W
Biomed Pharmacother; 2023 Sep; 165():115009. PubMed ID: 37343435
[TBL] [Abstract][Full Text] [Related]
10. Chondroitin sulfate-based universal nanoparticle delivers angiogenic inhibitor and paclitaxel to exhibit a combination of chemotherapy and anti-angiogenic therapy.
Hou H; Li Y; Tang W; Gao D; Liu Z; Zhao F; Gao X; Ling P; Wang F; Sun F; Tan H
Int J Biol Macromol; 2024 May; 271(Pt 1):132520. PubMed ID: 38772463
[TBL] [Abstract][Full Text] [Related]
11. Microenvironment-sensing, nanocarrier-mediated delivery of combination chemotherapy for pancreatic cancer.
Ray P; Nair G; Ghosh A; Banerjee S; Golovko MY; Banerjee SK; Reindl KM; Mallik S; Quadir M
J Cell Commun Signal; 2019 Sep; 13(3):407-420. PubMed ID: 30915617
[TBL] [Abstract][Full Text] [Related]
12. Advancements of the Molecular Directed Design and Structure-Activity Relationship of Ferritin Nanocage.
Xia X; Li H; Zang J; Cheng S; Du M
J Agric Food Chem; 2024 Apr; 72(14):7629-7654. PubMed ID: 38518374
[TBL] [Abstract][Full Text] [Related]
13. Development of purification process for dual-function recombinant human heavy-chain ferritin by the investigation of genetic modification impact on conformation.
Yin S; Zhang B; Lin J; Liu Y; Su Z; Bi J
Eng Life Sci; 2021 Oct; 21(10):630-642. PubMed ID: 34690634
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional Lipid-Based Nanoparticles for Codelivery of Anticancer Drugs and siRNA for Treatment of Non-Small Cell Lung Cancer with Different Level of Resistance and EGFR Mutations.
Majumder J; Minko T
Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371754
[TBL] [Abstract][Full Text] [Related]
15. Adenomatous Polyposis Coli loss controls cell cycle regulators and response to paclitaxel in MDA-MB-157 metaplastic breast cancer cells.
Astarita EM; Maloney SM; Hoover CA; Berkeley BJ; VanKlompenberg MK; Nair TM; Prosperi JR
PLoS One; 2021; 16(8):e0255738. PubMed ID: 34370741
[TBL] [Abstract][Full Text] [Related]
16. Ferritin: A Multifunctional Nanoplatform for Biological Detection, Imaging Diagnosis, and Drug Delivery.
Song N; Zhang J; Zhai J; Hong J; Yuan C; Liang M
Acc Chem Res; 2021 Sep; 54(17):3313-3325. PubMed ID: 34415728
[TBL] [Abstract][Full Text] [Related]
17. Phase 1, pharmacogenomic, dose-expansion study of pegargiminase plus pemetrexed and cisplatin in patients with ASS1-deficient non-squamous non-small cell lung cancer.
Szlosarek PW; Wimalasingham AG; Phillips MM; Hall PE; Chan PY; Conibear J; Lim L; Rashid S; Steele J; Wells P; Shiu CF; Kuo CL; Feng X; Johnston A; Bomalaski J; Ellis S; Grantham M; Sheaff M
Cancer Med; 2021 Oct; 10(19):6642-6652. PubMed ID: 34382365
[TBL] [Abstract][Full Text] [Related]
18. Single Ferritin Nanocages Expressing SARS-CoV-2 Spike Variants to Receptor and Antibodies.
Padariya M; Kalathiya U
Vaccines (Basel); 2024 Apr; 12(5):. PubMed ID: 38793697
[TBL] [Abstract][Full Text] [Related]
19. Ferritin-based nanomedicine for disease treatment.
Zhu Y; Zhu Y; Cao T; Liu X; Liu X; Yan Y; Shi Y; Wang JC
Med Rev (2021); 2023 Feb; 3(1):49-74. PubMed ID: 37724111
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
